CJ 11974.
D000818:Animals; D000932:Antiemetics / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000009:adverse effects; D001555:Benzene Derivatives / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D006801:Humans; D064729:Neurokinin-1 Receptor Antagonists; D010919:Placebos; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy*
D000932:Antiemetics; D000970:Antineoplastic Agents; D001555:Benzene Derivatives; C120871:CJ 11974; D064729:Neurokinin-1 Receptor Antagonists; D010919:Placebos